Literature DB >> 26250493

Unravelling the complexity of COPD by microRNAs: it's a small world after all.

Emmanuel T Osei1, Laura Florez-Sampedro1, Wim Timens2, Dirkje S Postma3, Irene H Heijink4, Corry-Anke Brandsma5.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease and is currently the fourth leading cause of death worldwide. Chronic inflammation and repair processes in the small airways are characteristic of COPD. Despite extensive efforts from researchers and industry, there is still no cure for COPD, hence an urgent need for new therapeutic alternatives. MicroRNAs are such an option; they are small noncoding RNAs involved in gene regulation. Their importance has been shown with respect to maintaining the balance between health and disease. Although previous reviews have discussed the expression of microRNAs related to lung disease, a detailed discussion regarding the function of differential miRNA expression in the pathogenesis of COPD is lacking.In this review we link the expression of microRNAs to different features of COPD and explain their importance in the pathogenesis of this disease. We further discuss their potential to contribute to the development of future therapeutic strategies.
Copyright ©ERS 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26250493     DOI: 10.1183/13993003.02139-2014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

1.  Lycopene Inhibits Smoke-Induced Chronic Obstructive Pulmonary Disease and Lung Carcinogenesis by Modulating Reverse Cholesterol Transport in Ferrets.

Authors:  Jelena Mustra Rakic; Chun Liu; Sudipta Veeramachaneni; Dayong Wu; Ligi Paul; C-Y Oliver Chen; Lynne M Ausman; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2019-06-08

2.  MicroRNAs as Therapeutic Targets in Lung Disease: Prospects and Challenges.

Authors:  Tadashi Sato; Hario Baskoro; Stephen I Rennard; Kuniaki Seyama; Kazuhisa Takahashi
Journal:  Chronic Obstr Pulm Dis       Date:  2015-12-14

Review 3.  Exosomes in immunoregulation of chronic lung diseases.

Authors:  K P Hough; D Chanda; S R Duncan; V J Thannickal; J S Deshane
Journal:  Allergy       Date:  2016-12-08       Impact factor: 13.146

4.  Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.

Authors:  Jens Köhler; Martin Schuler; Thomas Christoph Gauler; Stefanie Nöpel-Dünnebacke; Maike Ahrens; Andreas-Claudius Hoffmann; Stefan Kasper; Felix Nensa; Benedikt Gomez; Maria Hahnemann; Frank Breitenbuecher; Danjouma Cheufou; Filiz Özkan; Kaid Darwiche; Mathias Hoiczyk; Henning Reis; Stefan Welter; Wilfried Ernst Erich Eberhardt; Martin Eisenacher; Helmut Teschler; Georgios Stamatis; Wolff Schmiegel; Stephan Albrecht Hahn; Alexander Baraniskin
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-19       Impact factor: 4.553

Review 5.  A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.

Authors:  Peter G Shields; Micah Berman; Theodore M Brasky; Jo L Freudenheim; Ewy Mathe; Joseph P McElroy; Min-Ae Song; Mark D Wewers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-22       Impact factor: 4.254

6.  microRNA-149-5p mediates the PM2.5-induced inflammatory response by targeting TAB2 via MAPK and NF-κB signaling pathways in vivo and in vitro.

Authors:  Qiuyue Li; Siling Li; Chunjie Xu; Jing Zhao; Lin Hou; Fuyang Jiang; Zhonghui Zhu; Yan Wang; Lin Tian
Journal:  Cell Biol Toxicol       Date:  2021-07-31       Impact factor: 6.691

7.  A disintegrin and metalloproteinase domain-15 deficiency leads to exaggerated cigarette smoke-induced chronic obstructive pulmonary disease (COPD)-like disease in mice.

Authors:  Xiaoyun Wang; Joselyn Rojas-Quintero; Duo Zhang; Takahiro Nakajima; Katherine H Walker; Hong Yong Peh; Yuhong Li; Quynh-Anh Fucci; Yohannes Tesfaigzi; Caroline A Owen
Journal:  Mucosal Immunol       Date:  2020-07-20       Impact factor: 7.313

8.  A Disintegrin and A Metalloproteinase-9 (ADAM9): A Novel Proteinase Culprit with Multifarious Contributions to COPD.

Authors:  Xiaoyun Wang; Francesca Polverino; Joselyn Rojas-Quintero; Duo Zhang; José Sánchez; Ilyas Yambayev; Eva Lindqvist; Robert Virtala; Ratko Djukanovic; Donna E Davies; Susan Wilson; Rory O'Donnell; Danen Cunoosamy; Petra Hazon; Andrew Higham; Dave Singh; Henric Olsson; Caroline A Owen
Journal:  Am J Respir Crit Care Med       Date:  2018-06-04       Impact factor: 21.405

9.  Role of miRNA-181a-2-3p in cadmium-induced inflammatory responses of human bronchial epithelial cells.

Authors:  Jeeyoung Kim; Dong Yeop Kim; Hye-Ryeon Heo; Sun Shim Choi; Seok-Ho Hong; Woo Jin Kim
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

10.  MiR-221-3p and miR-92a-3p enhances smoking-induced inflammation in COPD.

Authors:  Yahui Shen; Huiyu Lu; Guixian Song
Journal:  J Clin Lab Anal       Date:  2021-06-07       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.